Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

NCT01052662 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: Memantine
DRUG: Memantine
DRUG: Placebo

Sponsor

University of Massachusetts, Worcester

Collaborators

[object Object]